All
Research
Education
Solutions
AR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Sign In
Department of Neurology
Nan Liu has not added Biography.
If you are Nan Liu and would like to personalize this page please email our Author Liaison for assistance.
Optimal Delay Time of CT Perfusion for Predicting Cerebral Parenchymal Hematoma After Intra-Arterial tPA Treatment.
Frontiers in neurology , 2018 | Pubmed ID: 30186221
Increased expression of EZH2 indicates aggressive potential of urothelial carcinoma of the bladder in a Chinese population.
Scientific reports Dec, 2018 | Pubmed ID: 30542123
Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway.
Medical science monitor : international medical journal of experimental and clinical research May, 2019 | Pubmed ID: 31042695
GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
OncoTargets and therapy , 2019 | Pubmed ID: 31571910
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study.
Cancer treatment and research communications , 2021 | Pubmed ID: 33848805
Circulating tumor DNA genomic profiling reveals the complicated olaparib-resistance mechanism in prostate cancer salvage therapy: A case report.
World journal of clinical cases Apr, 2022 | Pubmed ID: 35611209
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.
Cardiovascular research May, 2023 | Pubmed ID: 36464772
Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer.
British journal of cancer Mar, 2023 | Pubmed ID: 36681728
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer.
Cancer genetics Aug, 2023 | Pubmed ID: 37487324
Corrigendum to "Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer" [Cancer Genetics Volumes 276-277, August 2023, Pages 48-59].
Cancer genetics Nov, 2023 | Pubmed ID: 37734143
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models.
Translational oncology Jan, 2024 | Pubmed ID: 37897831
Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis.
Journal of advanced research Nov, 2024 | Pubmed ID: 39547438
Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume 39 (2024) 101803].
Translational oncology Feb, 2025 | Pubmed ID: 39848760
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.
Journal of translational medicine Feb, 2025 | Pubmed ID: 40012053
PLA Army General Hospital
Chongqing University Cancer Hospital
Dandan Li*,1,2,
Hóngyi Zhào*,2,3,
Wei Wei2,
Nan Liu2,
Yonghua Dr. Huang2
1Department of Neurology, Second Hospital of Shanxi Medical University,
2Department of Neurology, PLA Army General Hospital,
3Department of Neurology, NO 261 Hospital of PLA
Junyong Dai*,1,
Xianli Tang*,1,
Teng Zhang1,
DaWei Zhu1,
Yanping Song1,
Nan Liu1,
Jun Li1
1Department of Urological Oncology Surgery, Chongqing University Cancer Hospital
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved
We use cookies to enhance your experience on our website.
By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.
Learn More